Client News

CARBIOS and Hündgen Enter Supply Agreement for World’s First PET Biorecycling Plant

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024

Newron Announces Positive Top-Line Results from Potentially Pivotal Phase II/III Study 008A with Evenamide in Schizophrenia Patients

Medigene AG Reports Financial Results and Business Update for Q1 2024

CARBIOS Celebrates the Groundbreaking of its PET Biorecycling Plant, a World First, with its Partners

Affluent Medical: 2023 Financial Results and Update on Clinical Activities under Development

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

Medigene Presents Streamlined 6-Day, High Stemness TCR-T Therapy Production Process

Formycon Reports Audited Annual Results for the Financial Year 2023 – Looking Back on a Successful Operative Year and Exceeded Guidance

InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event